Half of Medtech Companies Expect Employee Numbers to Increase During Q4 2013
Half of medical technology companies expect their employee numbers to increase during Q4 2013, according to the latest survey, published today, by the Irish Medical Device Association (IMDA), a sector within Ibec. As many as 42% said they expected employee numbers to remain the same and the remaining 8% said expected a slight decrease.
The survey asked medical technology companies what they thought Q4 2013 would bring in terms of jobs, sales, productivity and R&D. A summary of the outcomes includes:
- 50% of medical technology companies say that they expect employee numbers to increase during Q4 2013
- 65% expect total sales to increase in that time
- 55% expect export sales to increase
- 41% expect domestic sales to increase
- 78% expect productivity to increase
- 57% expect R&D expenditure to increase
The survey findings were published to coincide with the announcement of the shortlist for this year’s Medical Technology Excellence Awards. A total of nine medical technology companies were shortlisted. The Medical Technology Excellence Awards recognise and reward best practice in the medical technology sector in Ireland.
The shortlist for the Overall Medical Technology Company of the Year Award is:
- Abbott Diagnostics (Longford)
- Aerogen Ltd
- Medtronic
- Nypro Healthcare Ireland
The shortlist for the Medical Technology Academic Award, encompassing the Emerging Medical Technology award, is:
- Arann Technologies (Dublin City University)
- BioInnovate Ireland
- Galway-Mayo Institute of Technology
- National University of Ireland Galway
- University of Limerick
Commenting on the research findings Sinead Keogh, IMDA Director (pictured) said, “This research shows that medical technology companies in Ireland are continuing the growth trend, with many expecting employee numbers, total sales and productivity, to increase during the last quarter. These are signs that the industry is seeing strong performance and is well positioned into the future.”
Andrew Vogelaar, Head of Medical Technologies, IDA Ireland said, “The research figures for R&D investment clearly demonstrate the long-term commitment that medical technology companies are making to Ireland. It is very positive for the sector and indicates that the positive momentum which we have seen over the past few years will be sustained going into 2014 and beyond.”
Commenting on the shortlisted companies Colm MacFhionnlaoich, Manager Life Sciences Department, Enterprise Ireland said: “The companies shortlisted showcase the very best of the industry and highlight yet again this year that the companies operating here in Ireland, both indigenous and multinational, are world class, innovative and leading the way.”
The Awards which are sponsored by KPMG (platinum sponsor), Creganna-Tactx Medical and SteriPack (gold sponsors) and will take place on Thursday December 12, 2013, in the Radisson Blu hotel in Galway.